;PMID: 9374477
;source_file_1916.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..42] = [t:0..42]
;1)sentence:[e:48..144] = [t:48..144]
;2)sentence:[e:145..195] = [t:145..195]
;3)section:[e:199..261] = [t:199..261]
;4)section:[e:265..427] = [t:265..427]
;5)sentence:[e:431..653] = [t:431..653]
;6)sentence:[e:654..742] = [t:654..742]
;7)sentence:[e:743..853] = [t:743..853]
;8)sentence:[e:854..939] = [t:854..939]
;9)sentence:[e:940..1105] = [t:940..1105]
;10)sentence:[e:1106..1239] = [t:1106..1239]
;11)sentence:[e:1240..1447] = [t:1240..1447]
;12)sentence:[e:1448..1669] = [t:1448..1669]
;13)section:[e:1673..1717] = [t:1673..1717]

;section 0 Span:0..42
;J Biol Chem. 1997 Nov 28;272(48):30025-31.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..6] Biol) (NNP:[7..11] Chem) (.:[11..12] .)
        (CD:[13..17] 1997) (NNP:[18..21] Nov) (CD:[22..27] 28;27)
        (CD:[27..28] 2) (NN:[28..29] -LRB-) (CD:[29..31] 48)
        (-RRB-:[31..32] -RRB-) (::[32..33] :) (CD:[33..37] 3002)
        (CD:[37..41] 5-31) (.:[41..42] .)))

;sentence 1 Span:48..144
;Inhibition of the transcription of CYP1A1 gene by the upstream stimulatory 
;factor 1 in rabbits.
;[124..132]:substance:"factor 1"
(SENT
  (NP-HLN
    (NP (NN:[48..58] Inhibition))
    (PP (IN:[59..61] of)
      (NP
        (NP (DT:[62..65] the) (NN:[66..79] transcription))
        (PP (IN:[80..82] of)
          (NP (NN:[83..89] CYP1A1) (NN:[90..94] gene)))))
    (PP (IN:[95..97] by)
      (NP (DT:[98..101] the) (JJ:[102..110] upstream)
          (JJ:[111..122] stimulatory)
         (NN:[124..130] factor) (CD:[131..132] 1)))
    (PP-LOC (IN:[133..135] in)
      (NP (NNS:[136..143] rabbits)))
    (.:[143..144] .)))

;sentence 2 Span:145..195
;Competitive binding of USF1 with AhR.Arnt complex.
;[168..172]:substance:"USF1"
;[178..194]:substance:"AhR.Arnt complex"
(SENT
  (NP-HLN
    (NP (JJ:[145..156] Competitive) (NN:[157..164] binding))
    (PP (IN:[165..167] of)
      (NP (NN:[168..172] USF1)))
    (PP (IN:[173..177] with)
      (NP (NN:[178..186] AhR.Arnt) (NN:[187..194] complex)))
    (.:[194..195] .)))

;section 3 Span:199..261
;Takahashi Y, Nakayama K, Itoh S, Fujii-Kuriyama Y, Kamataki T.
(SEC
  (FRAG (NNP:[199..208] Takahashi) (NNP:[209..210] Y) (,:[210..211] ,)
        (NNP:[212..220] Nakayama) (NNP:[221..223] K,) (NNP:[224..228] Itoh)
        (NNP:[229..230] S) (,:[230..231] ,) (NNP:[232..238] Fujii-)
        (NNP:[238..246] Kuriyama) (NNP:[247..248] Y) (,:[248..249] ,)
        (NNP:[250..258] Kamataki) (NNP:[259..261] T.)))

;section 4 Span:265..427
;Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido 
;University, N12W6, Kita-ku, Sapporo, Hokkaido 060, Japan. 
;kamataki@pharm.hokudai.ac.jp
(SEC
  (FRAG (NNP:[265..273] Division) (IN:[274..276] of) (NNP:[277..281] Drug)
        (NNP:[282..292] Metabolism) (,:[292..293] ,) (NNP:[294..301] Faculty)
        (IN:[302..304] of) (NNP:[305..319] Pharmaceutical)
        (NNPS:[320..328] Sciences) (,:[328..329] ,) (NNP:[330..338] Hokkaido)
        (NNP:[340..350] University) (,:[350..351] ,) (NNP:[352..357] N12W6)
        (,:[357..358] ,) (NN:[359..366] Kita-ku) (,:[366..367] ,)
        (NNP:[368..375] Sapporo) (,:[375..376] ,) (NNP:[377..385] Hokkaido)
        (CD:[386..389] 060) (,:[389..390] ,) (NNP:[391..396] Japan)
        (.:[396..397] .) (``:[399..413] kamataki@pharm)
        (NN:[413..427] .hokudai.ac.jp)))

;sentence 5 Span:431..653
;A xenobiotic-responsive element (XRE)-binding factor(s) other than the
;AhR.Arnt  complex was found to inhibit the transcription of CYP1A1 gene in
;the liver from  adult rabbits, known to be nonresponsive to CYP1A1 inducers.
;[433..486]:substance:"xenobiotic-responsive element (XRE)-binding factor(s)"
;[502..519]:substance:"AhR.Arnt  complex"
;[637..643]:cyp450:"CYP1A1"
;[644..652]:substance:"inducers"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[431..432] A)
        
        (ADJP
          (NML
            (NML
              (NML (JJ:[433..443] xenobiotic) (HYPH:[443..444] -)
                   (JJ:[444..454] responsive))
              (NN:[455..462] element))
            (NML (-LRB-:[463..464] -LRB-) (NN:[464..467] XRE)
                 (-RRB-:[467..468] -RRB-)))
          (HYPH:[468..469] -) (VBG:[469..476] binding))
        (NN:[477..486] factor-LRB-s-RRB-))
      (ADJP (JJ:[487..492] other)
        (PP (IN:[493..497] than)
          (NP (DT:[498..501] the)
             (NN:[502..510] AhR.Arnt) (NN:[512..519] complex)))))
    (VP (VBD:[520..523] was)
      (VP (VBN:[524..529] found)
        (S
          (NP-SBJ-1 (-NONE-:[529..529] *))
          (VP (TO:[530..532] to)
            (VP (VB:[533..540] inhibit)
              (NP
                (NP (DT:[541..544] the) (NN:[545..558] transcription))
                (PP (IN:[559..561] of)
                  (NP
                    (NP
                      (NP (NN:[562..568] CYP1A1) (NN:[569..573] gene))
                      (PP-LOC (IN:[574..576] in)
                        (NP
                          (NP (DT:[577..580] the) (NN:[581..586] liver))
                          (PP (IN:[587..591] from)
                            (NP (JJ:[593..598] adult) (NNS:[599..606] rabbits))))))
                    (,:[606..607] ,)
                    (VP (VBN:[608..613] known)
                      (S
                        (NP-SBJ (-NONE-:[613..613] *))
                        (VP (TO:[614..616] to)
                          (VP (VB:[617..619] be)
                            (ADJP-PRD (JJ:[620..633] nonresponsive)
                              (PP (TO:[634..636] to)
                                (NP (NN:[637..643] CYP1A1)
                                    (NNS:[644..652] inducers))))))))))))))))
    (.:[652..653] .)))

;sentence 6 Span:654..742
;The constitutive  factor(s) in liver nuclear extracts bound to the core
;sequence of XRE.
;[738..741]:substance:"XRE"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[654..657] The) (JJ:[658..670] constitutive)
          (NN:[672..681] factor-LRB-s-RRB-))
      (PP-LOC (IN:[682..684] in)
        (NP (NN:[685..690] liver) (JJ:[691..698] nuclear)
            (NNS:[699..707] extracts))))
    (VP (VBD:[708..713] bound)
      (PP (TO:[714..716] to)
        (NP
          (NP (DT:[717..720] the) (NN:[721..725] core) (NN:[726..734] sequence))
          (PP (IN:[735..737] of)
            (NP (NN:[738..741] XRE))))))
    (.:[741..742] .)))

;sentence 7 Span:743..853
;The  binding was eliminated by the presence of an excess amount of the
;AhR.Arnt  complex synthesized in vitro.
;[814..831]:substance:"AhR.Arnt  complex"
(SENT
  (S
    (NP-SBJ-1 (DT:[743..746] The) (NN:[748..755] binding))
    (VP (VBD:[756..759] was)
      (VP (VBN:[760..770] eliminated)
        (NP-1 (-NONE-:[770..770] *))
        (PP-MNR (IN:[771..773] by)
          (NP
            (NP (DT:[774..777] the) (NN:[778..786] presence))
            (PP (IN:[787..789] of)
              (NP
                (NP (DT:[790..792] an) (JJ:[793..799] excess)
                    (NN:[800..806] amount))
                (PP (IN:[807..809] of)
                  (NP
                    (NP (DT:[810..813] the)
                       (NN:[814..822] AhR.Arnt) (NN:[824..831] complex))
                    (VP (VBN:[832..843] synthesized)
                      (NP (-NONE-:[843..843] *))
                      (ADVP (FW:[844..846] in) (FW:[847..852] vitro)))))))))))
    (.:[852..853] .)))

;sentence 8 Span:854..939
;To identify the constitutive factor(s), a sequence  similar to rabbit XRE was
;sought.
;[924..927]:substance:"XRE"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[854..854] *))
      (VP (TO:[854..856] To)
        (VP (VB:[857..865] identify)
          (NP (DT:[866..869] the) (JJ:[870..882] constitutive)
              (NN:[883..892] factor-LRB-s-RRB-)))))
    (,:[892..893] ,)
    (NP-SBJ-1
      (NP (DT:[894..895] a) (NN:[896..904] sequence))
      (ADJP (JJ:[906..913] similar)
        (PP (TO:[914..916] to)
          (NP (NN:[917..923] rabbit) (NN:[924..927] XRE)))))
    (VP (VBD:[928..931] was)
      (VP (VBN:[932..938] sought)
        (NP-1 (-NONE-:[938..938] *))))
    (.:[938..939] .)))

;sentence 9 Span:940..1105
;It was found that the sequence of rabbit XRE  overlapped with that of the
;upstream stimulatory factor 1 (USF1)-binding site in  the mouse
;metallothionein I promoter.
;[981..984]:substance:"XRE"
;[1014..1043]:substance:"upstream stimulatory factor 1"
;[1045..1049]:substance:"USF1"
;[1078..1095]:substance:"metallothionein I"
;[1096..1104]:substance:"promoter"
(SENT
  (S
    (NP-SBJ-1
      (NP (PRP:[940..942] It))
      (SBAR-2 (-NONE-:[942..942] *ICH*)))
    (VP (VBD:[943..946] was)
      (VP (VBN:[947..952] found)
        (NP-1 (-NONE-:[952..952] *))
        (SBAR-2 (IN:[953..957] that)
          (S
            (NP-SBJ
              (NP (DT:[958..961] the) (NN:[962..970] sequence))
              (PP (IN:[971..973] of)
                (NP (NN:[974..980] rabbit) (NN:[981..984] XRE))))
            (VP (VBD:[986..996] overlapped)
              (PP (IN:[997..1001] with)
                (NP
                  (NP (DT:[1002..1006] that))
                  (PP (IN:[1007..1009] of)
                    (NP (DT:[1010..1013] the)
                      (ADJP
                        (NML
                          (NML (JJ:[1014..1022] upstream)
                               (JJ:[1023..1034] stimulatory)
                               (NN:[1035..1041] factor) (CD:[1042..1043] 1))
                          (NML (-LRB-:[1044..1045] -LRB-) (NN:[1045..1049] USF1)
                               (-RRB-:[1049..1050] -RRB-)))
                        (HYPH:[1050..1051] -) (VBG:[1051..1058] binding))
                      (NN:[1059..1063] site)))))
              (PP-LOC (IN:[1064..1066] in)
                (NP (DT:[1068..1071] the) (NN:[1072..1077] mouse)
                  (NML (NN:[1078..1093] metallothionein) (CD:[1094..1095] I))
                  (NN:[1096..1104] promoter))))))))
    (.:[1104..1105] .)))

;sentence 10 Span:1106..1239
;In fact, a super shift assay using a  specific antibody against human USF1
;indicated that USF1 was capable of binding  to rabbit XRE.
;[1153..1161]:substance:"antibody"
;[1176..1180]:substance:"USF1"
;[1196..1200]:substance:"USF1"
;[1235..1238]:substance:"XRE"
(SENT
  (S
    (PP (IN:[1106..1108] In)
      (NP (NN:[1109..1113] fact)))
    (,:[1113..1114] ,)
    (NP-SBJ
      (NP (DT:[1115..1116] a)
        (NML (JJ:[1117..1122] super) (NN:[1123..1128] shift))
        (NN:[1129..1134] assay))
      (VP (VBG:[1135..1140] using)
        (NP
          (NP (DT:[1141..1142] a) (JJ:[1144..1152] specific)
              (NN:[1153..1161] antibody))
          (PP (IN:[1162..1169] against)
            (NP (JJ:[1170..1175] human) (NN:[1176..1180] USF1))))))
    (VP (VBD:[1181..1190] indicated)
      (SBAR (IN:[1191..1195] that)
        (S
          (NP-SBJ (NN:[1196..1200] USF1))
          (VP (VBD:[1201..1204] was)
            (ADJP-PRD (JJ:[1205..1212] capable)
              (PP (IN:[1213..1215] of)
                (S-NOM
                  (NP-SBJ (-NONE-:[1215..1215] *))
                  (VP (VBG:[1216..1223] binding)
                    (PP (TO:[1225..1227] to)
                      (NP (NN:[1228..1234] rabbit) (NN:[1235..1238] XRE)))))))))))
    (.:[1238..1239] .)))

;sentence 11 Span:1240..1447
;Additionally, the AhR.Arnt-mediated activation of XRE-TK/Luc  reporter gene
;in RK13 cells was blocked by the transfection with a USF1  expression vector
;with the amounts of the expression vector transfected.
;[1258..1266]:substance:"AhR.Arnt"
;[1369..1373]:substance:"USF1"
(SENT
  (S
    (ADVP (RB:[1240..1252] Additionally))
    (,:[1252..1253] ,)
    (NP-SBJ-1
      (NP (DT:[1254..1257] the)
        (ADJP (NN:[1258..1266] AhR.Arnt) (HYPH:[1266..1267] -)
              (VBN:[1267..1275] mediated))
        (NN:[1276..1286] activation))
      (PP (IN:[1287..1289] of)
        (NP
          (NP
            (NML (NN:[1290..1296] XRE-TK) (SYM:[1296..1297] /)
                 (NN:[1297..1300] Luc))
            (NN:[1302..1310] reporter) (NN:[1311..1315] gene))
          (PP (IN:[1316..1318] in)
            (NP (NN:[1319..1323] RK13) (NNS:[1324..1329] cells))))))
    (VP (VBD:[1330..1333] was)
      (VP (VBN:[1334..1341] blocked)
        (NP-1 (-NONE-:[1341..1341] *))
        (PP (IN:[1342..1344] by)
          (NP-LGS
            (NP (DT:[1345..1348] the) (NN:[1349..1361] transfection))
            (PP (IN:[1362..1366] with)
              (NP (DT:[1367..1368] a) (NN:[1369..1373] USF1)
                  (NN:[1375..1385] expression) (NN:[1386..1392] vector)))))
        (PP (IN:[1393..1397] with)
          (NP
            (NP (DT:[1398..1401] the) (NNS:[1402..1409] amounts))
            (PP (IN:[1410..1412] of)
              (NP
                (NP (DT:[1413..1416] the) (NN:[1417..1427] expression)
                    (NN:[1428..1434] vector))
                (VP (VBN:[1435..1446] transfected)
                  (NP (-NONE-:[1446..1446] *)))))))))
    (.:[1446..1447] .)))

;sentence 12 Span:1448..1669
;These  results indicate that the XRE of the rabbit CYP1A1 gene is recognized
;by the  basic helix-loop-helix proteins to regulate the expression of CYP1A1
;in both an  agonistic (AhR.Arnt) and an antagonistic (USF1) manner.
;[1481..1484]:substance:"XRE"
;[1595..1601]:cyp450:"CYP1A1"
;[1625..1633]:substance:"AhR.Arnt"
;[1656..1660]:substance:"USF1"
(SENT
  (S
    (NP-SBJ (DT:[1448..1453] These) (NNS:[1455..1462] results))
    (VP (VBP:[1463..1471] indicate)
      (SBAR (IN:[1472..1476] that)
        (S
          (NP-SBJ-2
            (NP (DT:[1477..1480] the) (NN:[1481..1484] XRE))
            (PP (IN:[1485..1487] of)
              (NP (DT:[1488..1491] the) (NN:[1492..1498] rabbit)
                  (NN:[1499..1505] CYP1A1) (NN:[1506..1510] gene))))
          (VP (VBZ:[1511..1513] is)
            (VP (VBN:[1514..1524] recognized)
              (NP-2 (-NONE-:[1524..1524] *))
              (PP (IN:[1525..1527] by)
                (NP-LGS (DT:[1528..1531] the) (JJ:[1533..1538] basic)
                  (NML (NN:[1539..1544] helix) (HYPH:[1544..1545] -)
                       (NN:[1545..1549] loop) (HYPH:[1549..1550] -)
                       (NN:[1550..1555] helix))
                  (NNS:[1556..1564] proteins)))
              (S-ADV
                (NP-SBJ (-NONE-:[1564..1564] *))
                (VP (TO:[1565..1567] to)
                  (VP (VB:[1568..1576] regulate)
                    (NP
                      (NP (DT:[1577..1580] the) (NN:[1581..1591] expression))
                      (PP (IN:[1592..1594] of)
                        (NP (NN:[1595..1601] CYP1A1))))
                    (PP (IN:[1602..1604] in)
                      (NP (CC:[1605..1609] both)
                        (NP
                          (NP (DT:[1610..1612] an)
                            (ADJP (JJ:[1614..1623] agonistic)
                              (PRN (-LRB-:[1624..1625] -LRB-)
                                (NP (NN:[1625..1633] AhR.Arnt))
                                (-RRB-:[1633..1634] -RRB-)))
                            (NML-1 (-NONE-:[1634..1634] *P*)))
                          (CC:[1635..1638] and)
                          (NP (DT:[1639..1641] an)
                            (ADJP (JJ:[1642..1654] antagonistic)
                              (PRN (-LRB-:[1655..1656] -LRB-)
                                (NP (NN:[1656..1660] USF1))
                                (-RRB-:[1660..1661] -RRB-)))
                            (NML-1 (NN:[1662..1668] manner))))))))))))))
    (.:[1668..1669] .)))

;section 13 Span:1673..1717
;PMID: 9374477 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1673..1677] PMID) (::[1677..1678] :) (CD:[1679..1686] 9374477)
        (NN:[1687..1688] -LSB-) (NNP:[1688..1694] PubMed) (::[1695..1696] -)
        (NN:[1697..1704] indexed) (IN:[1705..1708] for)
        (NNP:[1709..1717] MEDLINE-RSB-)))
